GENENTECH, INC for GENENTECH INC
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 20, 2011 | $1,242,641 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 30, 2011 | $1,242,641 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare issues; payment policies for prescription drugs; implementation of H.R.1; Medicare Prescription Drug and Modernization Act of 2003; Issues relating to PDUFA, stimulus; physician payment disclosure including S.301; Physician Payments Sunshine Act of 2009; HR 3962, Affordable Health Care for Americans Act; HR 3590, Patient Protection and Affordable Care Act; H.R.4872, the Reconciliation Act of 2010; Follow-on biologics including H.R. 154, the Pathway to Biosimilars Act; S726/H.R. 1427 Promoting innovation and access to Life Savings Medicines Act; HR 3962, Affordable Health Care for America Act; Compartiveffectiveness legislation S. 1213; Patient-Centered Outcomes Research Act of 2009; HR 3200, America's Health Future Act; H.R. 1548-Pathway for Dissimilar Act; Legislative changes in health care reform bill regarding dissimilar; Follow-on biolotics provisions in P.L. 111-148 "Patient protection and Affordable Care Act", Affordable Health Choice Act; American Health Future Act of 2009; Pharmaceutical Import Safety legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Budget/Appropriations BUD
Various issues related to the budget and appropriations process
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Food Industry (safety, labeling, etc.) FOO
Monitor and report on food safety and supply chain issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Trade (domestic/foreign) TRD
Monitor issues related to export rules and regulations, international patent issues, WTO matters and other international issues impacting biotech and pharmaceuticals.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Taxation/Internal Revenue Code TAX
Monitor and report on corporate tax issues; general tax issues and tax extenders
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Copyright/Patent/Trademark CPT
S.515 & H.R. 1260 - Patent Reform Act of 2009
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Health Issues HCR
Labor HHS appropriations stock piling anti-virals for pandemic influenza; Cancer Research Issues - S.3686/HR_, Labor, HHS Appropriations Bill for FY2011; Monitoring the implementation for the Patient Protection and Affordable Care Act, including provisions related to comparative effectiveness research and a regulatory pathway for biosimilars; H.R.1 - Pandemic influenza funding: H.R.1105 Omnibus Appropriations Act of 2010, Food Safety Bill, H.R. 4872 Health Care& Education Reconciliation Act of 2011; issues concerning clincial trials; general health care reform (Patient Protection and Affordable Care Act); Congressional oversight issues; FDA approval and enforcement issues; Pandemic preparedness; Tamiflu; Avastin-breast cancer; following all issues related to health care reform; S.726/HR 1427 - promotiong innovation and access to life-saving Medicine Act; HR 1548 - Pathway for Biosimilars Act; General support for Genentech products; monitor and report on issues relate to implementation to health care reform; H.R. 1548 - Pathway for Biosimilars Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | Assoc. Dir., Government Affairs |
| DARIN GARDNER | Director, Government Affairs |
| ANNA GRIFFIN | Director, Government Affairs |
| ELI KOGAN New | Assoc. Dir., Government Affairs |
| EVAN MORRIS | Vice President, Government Affairs |
| KATHERINE RAAB | Director, Government Affairs |
Homeland Security HOM
Labor HHS Appropriations - S.3230 & H.R. 3042, Homeland Security Appropriations S.3181 and HR 6947; Congress and Federal agencies: US House of Representatives: US Senate: HHS; Dept. of Homeland Security; Executive Office of the President; Office of Personnel Manangement; Dept., of Veteran Affairs
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID B BURT | — |
| DARIN GARDNER | — |
| ANNA GRIFFIN | — |
| ELI KOGAN New | — |
| EVAN MORRIS | — |
| KATHERINE RAAB | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.